Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Healing & Recovery
Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity.
Peptide B
Healing & Recovery
Broad neuropeptide with anti-inflammatory, immunomodulatory, and vasodilatory activity.
Typical vial
5 mg
Typical dose
2000-5000 mcg
Half-life
~6-8 hours
FDA status
Not FDA approved for human use.
Typical vial
5 mg
Typical dose
50-200 (intranasal) mcg
Half-life
~2 minutes (plasma); longer functional duration via tissue distribution
FDA status
Not FDA approved as therapeutic. VIP analog aviptadil receiv…
TB-500 effects
VIP (Vasoactive Intestinal Peptide) effects
TB-500 side effects
VIP (Vasoactive Intestinal Peptide) side effects
TB-500 dosing ranges
Acute injury healing
2000-5000 mcg · Twice weekly · 4-6 weeks
Maintenance and recovery
2000 mcg · Once weekly · 4-8 weeks
VIP (Vasoactive Intestinal Peptide) dosing ranges
Intranasal CIRS protocol (off-label)
50 mcg · 4 sprays daily · Per Shoemaker protocol; months to years for full restoration
Research / immunomodulation
Variable per protocol · Per protocol · Per protocol
TB-500: Synthetic fragment of Thymosin Beta-4 with potent tissue repair activity. Typical dose 2000-5000 mcg. VIP (Vasoactive Intestinal Peptide): Broad neuropeptide with anti-inflammatory, immunomodulatory, and vasodilatory activity. Typical dose 50-200 (intranasal) mcg. Both fall under the Healing & Recovery category.
Stacking TB-500 with VIP (Vasoactive Intestinal Peptide) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
TB-500 is typically dosed: Twice weekly for Acute injury healing; Once weekly for Maintenance and recovery. VIP (Vasoactive Intestinal Peptide) is typically dosed: 4 sprays daily for Intranasal CIRS protocol (off-label); Per protocol for Research / immunomodulation.
TB-500: Not FDA approved for human use. VIP (Vasoactive Intestinal Peptide): Not FDA approved as therapeutic. VIP analog aviptadil received Emergency Use Authorization consideration for COVID-19 ARDS but not full approval.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free